What agencies at the local, state, federal, and/or international level provide information, regulatory oversight, or are otherwise implicated in addressing that topic?
The topic of interest I would like to focus on for my literature review would be the effects of antidepressants have on children during the perinatal and lactation stages. The federal agency that would provide regulatory oversight of the safety and efficacy of antidepressants would be the FDA. They oversee the clinical trial process and determine whether a medication gets to market. However, I do not think the FDA has regulatory policies to determine the effects antidepressants have on children.
That is a great topic. It would be interesting to see current data available on the use of psychotropic medications in pregnant or breastfeeding women. I believe it would be challenging to weigh the risk of the drug effects on the baby (or fetus) against the depression in the mother.
ReplyDeleteVery interesting topic. I can only imagine that antidepressants infants are exposed to in utero and after birth have an effect on their development. Having worked with pregnant women, many women that I have worked with stop taking antidepressants during pregnancy in order to avoid any issues with their infants. It will be very interesting to read what you find on this topic.
ReplyDelete